These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22495330)

  • 1. “Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema”.
    Kim SJ
    Retina; 2012 May; 32(5):1033; author reply 1033-4. PubMed ID: 22495330
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema.
    Elbendary AM; Shahin MM
    Retina; 2011 Nov; 31(10):2058-64. PubMed ID: 21765371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal injection of triamcinolone acetonide for diabetic macular edema.
    Kuhn F; Barker D
    Arch Ophthalmol; 2004 Jul; 122(7):1082-3; author reply 1086-8. PubMed ID: 15249385
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
    Wong R; Sherefat H; Bartholomew D; Horgan SE
    Arch Ophthalmol; 2004 Jul; 122(7):1082; author reply 1086-8. PubMed ID: 15249384
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal triamcinolone in diabetic macular edema.
    Aslam S; Malik N; Davies N
    Arch Ophthalmol; 2006 Oct; 124(10):1506-7; author reply 1507. PubMed ID: 17030730
    [No Abstract]   [Full Text] [Related]  

  • 6. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials.
    Flynn HW; Scott IU
    Arch Ophthalmol; 2005 Feb; 123(2):258-9. PubMed ID: 15710825
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
    Ozdemir H; Karacorlu M; Karacorlu SA
    Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of intravitreal triamcinolone acetonide for bevacizumab-resistant diabetic macular oedema.
    Kim JH; Lee TG; Lew YJ
    Acta Ophthalmol; 2015 Mar; 93(2):e178-9. PubMed ID: 25043969
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema.
    Penha FM; Maia M; Cardillo JA; Arevalo JF; Wu L; Rodriguez FJ; Berrocal MH; Farah ME;
    Acta Ophthalmol; 2012 Mar; 90(2):e160-1. PubMed ID: 21470386
    [No Abstract]   [Full Text] [Related]  

  • 13. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.
    Spandau UH; Derse M; Schmitz-Valckenberg P; Papoulis C; Jonas JB
    Br J Ophthalmol; 2005 Aug; 89(8):999-1003. PubMed ID: 16024853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema.
    Ozkiris A; Evereklioglu C; Erkiliç K; Tamçelik N; Mirza E
    Eur J Ophthalmol; 2004; 14(6):543-9. PubMed ID: 15638105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of intravitreal steroids for the treatment of diabetic macular edema.
    Bandello F; Preziosa C; Querques G; Lattanzio R
    Ophthalmic Res; 2014; 52(2):89-96. PubMed ID: 25195600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
    Salti H; Farah T
    Am J Ophthalmol; 2005 Nov; 140(5):958; author reply 958-9. PubMed ID: 16310498
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Kumar V; Ghosh B; Raina UK; Goel N
    Am J Ophthalmol; 2008 Dec; 146(6):974; author reply 974-5. PubMed ID: 19027427
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
    Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN
    Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Ho TC; Lai WW
    Ophthalmologica; 2006; 220(5):349-50; author reply 350. PubMed ID: 16954717
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.